Validation of the somatic symptom disorder—B Criteria Scale (SSD-12) in Bangladesh
PLOS ONE · 24.01.2025 · 20 (1) · e0318062
DOI: 10.1371/journal.pone.0318062 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, online erschienen am 24.01.2025. Verfasst von Sumaiya Habib und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Psychology, University of Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Somatoform Disorders, Medically Unexplained Symptoms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology (NST) Fellowship.
Abstract (Originalsprache)
Background
The absence of a reliable and valid Bangla instrument for measuring somatic symptom disorder hinders research and clinical activities in Bangladesh. The present study aimed at translating and validating the Somatic Symptom Disorder-B criteria (SSD-12).
Method
A cross-sectional design was used with purposively selected clinical (n = 100) and non-clinical (n = 100) samples. The clinical sample was collected from psychiatric departments at three hospitals, while the non-clinical sample was drawn from the local community. Exploratory (EFA) and confirmatory factor analysis (CFA) were conducted on the SSD-12, along with reliability and validity assessments.
Results
Results indicated satisfactory internal consistency reliability (Cronbach’s alpha = .94, split-half r = .93); criterion-related validity (r = .86, with Morey’s Somatic Complaints Scale); and construct validity (r = .64 with anxiety subscale and r = .57 with depression subscale of the Hospital Anxiety and Depression Scale) of the translated scale. In contrast to the three-factor structure of the original SSD-12, the Bangla version indicated a single-factor structure (accounting for 61.29% of the total variance). This scale also demonstrates its ability to distinguish between clinical and non-clinical participants (t 198 = 16.74, p < .01).
Conclusion
The Bangla translated SSD-12 has demonstrated strong psychometric properties, indicating its suitability for use in Bangladesh. This tool is expected to aid mental health practitioners in their clinical work by providing them with a quick assessment of their patients having somatic complaints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Psychology, University of Dhaka, Bangladesh.
ORCID-Profile: Muhammad Kamruzzaman Mozumder
Förderung
- National Science and Technology (NST) Fellowship
Zitieren
APA
Habib, S., & Mozumder, M. K. (2025). Validation of the somatic symptom disorder—B Criteria Scale (SSD-12) in Bangladesh. PLOS ONE, 20(1), e0318062. https://doi.org/10.1371/journal.pone.0318062
Vancouver
Habib S, Mozumder MK. Validation of the somatic symptom disorder—B Criteria Scale (SSD-12) in Bangladesh. PLOS ONE. 2025;20(1):e0318062. doi:10.1371/journal.pone.0318062
BibTeX
@article{Habib2025,
author = {Habib, Sumaiya and Mozumder, Muhammad Kamruzzaman},
title = {Validation of the somatic symptom disorder—B Criteria Scale (SSD-12) in Bangladesh},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0318062},
doi = {10.1371/journal.pone.0318062}
}
EUVIMED